The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.

SBI Mutual Fund acquired 0.54% stake in Alkem Laboratories for Rs 300 crore through open market transaction, increasing its ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an ...

Samprada & Nanhamati Singh Family Trust sold 6,41,712 shares (0.54 percent stake) of Alkem Laboratories Ltd in a bulk deal at ...

On Friday, the BSE Sensex dropped 424.90 points (0.56%) to close at 75,311.06, after sliding as much as 623.55 points (0.82%) ...

SBI Mutual Fund bought additional shares of Alkem Laboratories for Rs 300 crore, increasing its stake to 2.7%. The shares, totaling 6.41 lakh, were acquired at Rs 4,680 each. This transaction saw the ...

At 09.16 am shares of Alkem Labs were trading at Rs 4,700.50 on the NSE. Alkem Labs shares are down over 16 percent ...

State Bank of India Chairman C S Setty on Sunday said the largest Indian lender is targeting to be Net-Zero by 2055.

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of ...

The NSE Nifty 50 ended 117.25 points, or 0.51%, lower at 22,795.9, while the BSE Sensex closed 424.9 points, or 0.56%, lower at 75,311.06.

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

The Reserve Bank of India has imposed a penalty of Rs 39 lakh on Citibank N.A. for non-compliance with directions pertaining ...